# S4 TO 108 NCATS GENE THERAPY VECTOR

> **NIH NIH N02** · MEDICAL SCIENCE & COMPUTING, LLC · 2021 · $3,795,000

## Abstract

Produce and deliver a research grade gene therapy vector for a potential lead candidate for hereditary methylmalonic acidemias using AAV9 platform-based gene therapy vector platform.

## Key facts

- **NIH application ID:** 10497626
- **Project number:** 75N98020D00086-0-759802100357-1
- **Recipient organization:** MEDICAL SCIENCE & COMPUTING, LLC
- **Principal Investigator:** ANNA KOROLEVA
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $3,795,000
- **Award type:** —
- **Project period:** 2021-09-30 → 2022-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10497626

## Citation

> US National Institutes of Health, RePORTER application 10497626, S4 TO 108 NCATS GENE THERAPY VECTOR (75N98020D00086-0-759802100357-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10497626. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*